Show simple item record

dc.contributor.authorKrasny, L
dc.contributor.authorPaul, A
dc.contributor.authorWai, P
dc.contributor.authorHoward, BA
dc.contributor.authorNatrajan, RC
dc.contributor.authorHuang, PH
dc.date.accessioned2016-09-05T13:28:06Z
dc.date.issued2016-11-01
dc.identifier.citationThe Biochemical journal, 2016, 473 (21), pp. 3979 - 3995
dc.identifier.issn0264-6021
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/100
dc.identifier.eissn1470-8728
dc.identifier.doi10.1042/bcj20160686
dc.description.abstractThe matrisome is a complex and heterogeneous collection of extracellular matrix (ECM) and ECM-associated proteins that play important roles in tissue development and homeostasis. While several strategies for matrisome enrichment have been developed, it is currently unknown how the performance of these different methodologies compares in the proteomic identification of matrisome components across multiple tissue types. In the present study, we perform a comparative proteomic assessment of two widely used decellularisation protocols and two extraction methods to characterise the matrisome in four murine organs (heart, mammary gland, lung and liver). We undertook a systematic evaluation of the performance of the individual methods on protein yield, matrisome enrichment capability and the ability to isolate core matrisome and matrisome-associated components. Our data find that sodium dodecyl sulphate (SDS) decellularisation leads to the highest matrisome enrichment efficiency, while the extraction protocol that comprises chemical and trypsin digestion of the ECM fraction consistently identifies the highest number of matrisomal proteins across all types of tissue examined. Matrisome enrichment had a clear benefit over non-enriched tissue for the comprehensive identification of matrisomal components in murine liver and heart. Strikingly, we find that all four matrisome enrichment methods led to significant losses in the soluble matrisome-associated proteins across all organs. Our findings highlight the multiple factors (including tissue type, matrisome class of interest and desired enrichment purity) that influence the choice of enrichment methodology, and we anticipate that these data will serve as a useful guide for the design of future proteomic studies of the matrisome.
dc.formatPrint-Electronic
dc.format.extent3979 - 3995
dc.languageeng
dc.language.isoeng
dc.publisherPORTLAND PRESS LTD
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectExtracellular Matrix
dc.subjectAnimals
dc.subjectHumans
dc.subjectExtracellular Matrix Proteins
dc.subjectChromatography, Liquid
dc.subjectElectrophoresis, Polyacrylamide Gel
dc.subjectProteomics
dc.subjectTandem Mass Spectrometry
dc.titleComparative proteomic assessment of matrisome enrichment methodologies.
dc.typeJournal Article
dcterms.dateAccepted2016-09-02
rioxxterms.versionofrecord10.1042/bcj20160686
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2016-11
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfThe Biochemical journal
pubs.issue21
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrine control mechanisms
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Functional Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Functional Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Endocrine control mechanisms
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Functional Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Functional Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology
pubs.publication-statusPublished
pubs.volume473
pubs.embargo.termsNo embargo
icr.researchteamEndocrine control mechanisms
icr.researchteamFunctional Genomics
icr.researchteamMolecular and Systems Oncology
dc.contributor.icrauthorKrasny, Lukas
dc.contributor.icrauthorHoward, Beatrice
dc.contributor.icrauthorNatrajan, Rachael
dc.contributor.icrauthorHuang, Paul


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0